MAPT and Alzheimer disease: There is recent evidence that insulin has a role in proteostasis, influencing Aβ clearance and tau phosphorylation [14, 18, 44, 193], and that it plays a remarkable, putative role in the development of AD pathological markers [18, 44, 45].